PIEZO1 and cancer: To corroborate the oncogenic function of PIEZO1, we carried out functional tests that illustrated that depleting PIEZO1 hindered patient‐derived organoid growth, curtailed monolayer colony formation of cancer cells, and compromised GC cell invasion (Figure S6F–H).